CooperSurgical Launches the Reengineered Carter-Thomason&#0174 II Port Closure System

Published: Nov 07, 2012

TRUMBULL, Conn., Nov. 6, 2012 /PRNewswire/ -- CooperSurgical announced today the release of the new Carter-Thomason II Port Closure System, which ensures safer, quicker port site closure for average to obese patients undergoing a range of laparoscopic procedures. The system is comprised of two precisely engineered components including the advanced Suture Passer and Suture Guide.

(Photo: )
(Logo: )

"Building upon the strengths of the original Carter-Thomason Port CloseSure System, we have made significant advancements in design, functionality and safety. For health care providers, the Carter-Thomason II is an easy-to-use, intuitive surgical tool that offers precise, safe and repeatable port site closure," said Dr. Robert Auerbach, Senior Vice-President and Chief Medical Officer for CooperSurgical. "For patients, particularly obese patients, the Carter-Thomason II system provides full-thickness closure to prevent port site herniation for this high-risk group."

Because the Suture Guide is the only device on the market designed to be placed directly through the trocar, it precisely follows the port site track to assure complete closure, including fascia and peritoneum. This method maintains pneumoperitoneum, and ensures accurate placement of the Suture Passer for consistent and reproducible results with every closure. The guide also enables countertraction to create more working area within the abdomen, and provides a better approximation of tissue.

The new Suture Passer has been completely redesigned with longer, retractable grasping fingers that surgeons can deploy over a wider area for easier and safer retrieval of sutures within the abdominal cavity. When the grasping fingers are retracted, the tip of the needle seals to prevent coring of tissue.

The Carter-Thomason II Port Closure System ensures precise fascial closure for average to morbidly obese patients, effectively preventing port site herniation, a potential complication of minimally invasive surgeries.

About CooperSurgical
Since our founding in 1990, CooperSurgical has researched, developed and manufactured a wide range of trusted brands that have advanced the standard of women's health care. Our products are used by physicians and health care professionals in hospitals and their practices for a wide variety of procedures from basic annual gynecological exams to complex surgeries.

CooperSurgical, Inc., is a wholly owned subsidiary of The Cooper Companies (NYSE:COO). The company, headquartered in Trumbull, CT, produces and markets a wide array of products for use by women's health care clinicians. More information can be found at

SOURCE CooperSurgical, Inc.

Back to news